AstraZeneca chief Soriot lends GlaxoSmithKline's Walmsley CEO wisdom, support as activist investors press for change

As GlaxoSmithKline CEO Emma Walmsley faces a high-profile challenge from activist investor Elliott Management, she has won backing from an unexpected source: AstraZeneca chief Pascal Soriot.